NCT01588925View on ClinicalTrials.gov

Hearing Preservation Using Dexamethasone and Hyaluronic Acid for Cochlear Implantation

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

January 31, 2014

Conditions
Hearing Loss
Interventions
DEVICE

Cochlear Implantation

Cochlear implantation using Hybrid L24 Implant

DRUG

Cochlear Implantation+dexamethasone

Cochlear implantation using Hybrid L24 Implant,dexamethasone (4mg/ml) in the round window

DRUG

Cochlear Implantation+dexamethasone+hyaluronic acid

Cochlear implantation using Hybrid L24 Implant,dexamethasone (4mg/ml) in the round window and hyaluronic acid (10mg/ml) in the electrode array

Trial Locations (1)

Unknown

University of São Paulo General Hospital, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT01588925 - Hearing Preservation Using Dexamethasone and Hyaluronic Acid for Cochlear Implantation | Biotech Hunter | Biotech Hunter